Biliary cancer prevention and treatment

This collection will bring together cutting-edge research and clinical insights on biliary cancer diagnosis, management and care. Featuring contributions from oncologists, hepatobiliary surgeons and multidisciplinary specialists, these articles explore the latest advances in early detection, molecular profiling, surgical techniques, and systemic therapies for cholangiocarcinoma and gallbladder cancer. From emerging biomarkers to innovative treatment protocols, this collection will provide clinicians with evidence-based strategies for improving outcomes in patients facing these aggressive malignancies.

This Article Collection welcomes authors to submit Reviews, Original Research, Drug Profiles, and short Editorial articles. It welcomes original clinical and translational work in this field and will highlight recent findings and upcoming developments that will impact the future of hepato-biliary cancer patient care.

The benefit of publishing as part of an Article Collection is that they often become a key resource, driving a research community forward. This has a synergistic effect on every article in the Collection. The articles often receive more views and higher citation numbers as the Collections receive increased promotion via social media and our marketing team. 

If you are interested in contributing, or would like to learn more, then please reach out to the Commissioning Editor, Olivia Clovis-Corbett, who will be happy to assist.

About the Guest Adviser

Timothy Pawlik

Dr. Pawlik is Chair of Surgery at The Ohio State University Wexner Medical Center, holding the Urban Meyer III and Shelley Meyer Chair for Cancer Research. He earned degrees from Georgetown University and Tufts University School of Medicine, completing surgical training at the University of Michigan and advanced surgical oncology training at M. D. Anderson Cancer Center. He was awarded a PhD in Clinical Investigations from Johns Hopkins Bloomberg School of Public Health, a Masters in Theology from Harvard Divinity School, and an Executive MBA from The Ohio State University Fisher Business School.At Johns Hopkins (2005-2016), he served as Professor of Surgery and Oncology and Chief of Surgical Oncology. At Ohio State, he has recruited over 90 faculty members and leads a department ranked #9 for NIH funding with a top 10 surgical residency program.

Dr. Pawlik has published over 2,300 articles, edited 17 textbooks, and delivered 675+ invited talks across 40+ countries. He serves as Editor-in-Chief of Journal of Gastrointestinal Surgery, Deputy Editor of JAMA Surgery, and President of the Association for Academic Surgery Foundation. His clinical focus is hepatic and gastrointestinal oncology, with a focus on hepatic, gall bladder, small intestine, pancreatic and gastrointestinal cancers. Special areas of interest include prognosis, cancer care economics, and patient-physician communication.